Total pharmaceutical sales in Finland during February–October 2009 were EUR 1,464 (1,460) million in PPP, which represents growth of 0.3% compared to the same period in the previous year. The medicine reference pricing model that came into effect in April 2009 slowed down market growth.
Tamro Finland’s net sales in February–October were EUR 822 (789) million, an increase of 4.3%. Tamro Finland’s average market share for February–October was 53%. The company employed an average of 340 (343) people.
During the reporting period, Tamro Finland reached agreements with three new suppliers. The distribution will begin in January 2010. This is expected to increase Tamro Finland’s market share by approximately 2.5%.
The market growth for the full year 2009/10 is expected to be 0.5–1.5%.
